Edarbyclor 40 mg/12.5 mg
Edarbyclor 40 mg/12.5 mg is a medicine authorised by Swissmedic under authorisation number 63145. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 October 2014 and the authorisation is valid without a time limit. ATC code C09DA09 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 63145 |
|---|---|
| Name | Edarbyclor 40 mg/12.5 mg |
| Full name | Edarbyclor 40 mg/12.5 mg, Filmtabletten |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA09 |
| First authorisation | 28 October 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Edarbyclor 40 mg/12.5 mg, Filmtabletten | B | 28 October 2014 |
| 2 | Edarbyclor 40 mg/25 mg, Filmtabletten | B | 28 October 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 56 | Tablette(n) | C09DA09 | 02.07.2. | B |
| 11 | 28 | Tablette(n) | C09DA09 | 02.07.2. | B |
| 12 | 98 | Tablette(n) | C09DA09 | 02.07.2. | B |
| 7 | 56 | Tablette(n) | C09DA09 | 02.07.2. | B |
| 13 | 28 | Tablette(n) | C09DA09 | 02.07.2. | B |
| 14 | 98 | Tablette(n) | C09DA09 | 02.07.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Edarbyclor 40 mg/12.5 mg authorised in Switzerland?
Yes. Edarbyclor 40 mg/12.5 mg is authorised by Swissmedic under authorisation number 63145, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Edarbyclor 40 mg/12.5 mg have?
Edarbyclor 40 mg/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Edarbyclor 40 mg/12.5 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.